+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Scaffold Technology - Global Market Trajectory & Analytics

  • ID: 5304192
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • 3D Biotek LLC
  • Corning Inc.
  • Marticel GmbH
  • Molecular Matrix Inc.
  • NuVasive, Inc.
  • ReproCELL Europe Ltd.
Global Scaffold Technology Market to Reach $1.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Scaffold Technology estimated at US$1 Billion in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2027, growing at a CAGR of 7.7% over the analysis period 2020-2027. Hydrogels, one of the segments analyzed in the report, is projected to record a 8% CAGR and reach US$772.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Polymeric Scaffolds segment is readjusted to a revised 6.8% CAGR for the next 7-year period.



The U.S. Market is Estimated at $303.4 Million, While China is Forecast to Grow at 7.2% CAGR

The Scaffold Technology market in the U.S. is estimated at US$303.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$300.6 Million by the year 2027 trailing a CAGR of 7.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 6.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR.

Micropatterned Surface Microplates Segment to Record 7.3% CAGR

In the global Micropatterned Surface Microplates segment, USA, Canada, Japan, China and Europe will drive the 7.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$117.3 Million in the year 2020 will reach a projected size of US$192.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$198.9 Million by the year 2027.

Select Competitors (Total 34 Featured):
  • 3D Biotek LLC
  • Avacta Life Sciences Limited
  • Becton
  • Corning Inc.
  • Dickinson and Company
  • Marticel GmbH
  • Merck and Company
  • Molecular Matrix Inc.
  • Nanofiber Solutions
  • NuVasive, Inc.
  • Pelo Biotech GmbH
  • ReproCELL Europe Ltd.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3D Biotek LLC
  • Corning Inc.
  • Marticel GmbH
  • Molecular Matrix Inc.
  • NuVasive, Inc.
  • ReproCELL Europe Ltd.
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Scaffold Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Scaffold Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Hydrogels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Hydrogels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Polymeric Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Polymeric Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Micropatterned Surface Microplates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Micropatterned Surface Microplates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Nanofiber Based Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Nanofiber Based Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 11: World Current & Future Analysis for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 12: World 7-Year Perspective for Biotech & Pharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 13: World Current & Future Analysis for Research Laboratories & Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 14: World 7-Year Perspective for Research Laboratories & Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 15: World Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 16: World 7-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 17: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 18: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
III. MARKET ANALYSIS
  • UNITED STATES
  • Table 19: USA Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 20: USA 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
  • Table 21: USA Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 22: USA 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
  • CANADA
  • Table 23: Canada Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 24: Canada 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
  • Table 25: Canada Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 26: Canada 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
  • JAPAN
  • Table 27: Japan Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 28: Japan 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
  • Table 29: Japan Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 30: Japan 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
  • CHINA
  • Table 31: China Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: China 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
  • Table 33: China Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 34: China 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
  • EUROPE
  • Table 35: Europe Current & Future Analysis for Scaffold Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 36: Europe 7-Year Perspective for Scaffold Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 37: Europe Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 38: Europe 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
  • Table 39: Europe Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 40: Europe 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
  • FRANCE
  • Table 41: France Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 42: France 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
  • Table 43: France Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 44: France 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
  • GERMANY
  • Table 45: Germany Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 46: Germany 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
  • Table 47: Germany Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 48: Germany 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
  • ITALY
  • Table 49: Italy Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 50: Italy 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
  • Table 51: Italy Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 52: Italy 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
  • UNITED KINGDOM
  • Table 53: UK Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 54: UK 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
  • Table 55: UK Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 56: UK 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
  • REST OF EUROPE
  • Table 57: Rest of Europe Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 58: Rest of Europe 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
  • Table 59: Rest of Europe Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 60: Rest of Europe 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
  • ASIA-PACIFIC
  • Table 61: Asia-Pacific Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 62: Asia-Pacific 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
  • Table 63: Asia-Pacific Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 64: Asia-Pacific 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
  • REST OF WORLD
  • Table 65: Rest of World Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 66: Rest of World 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2020 & 2027
  • Table 67: Rest of World Current & Future Analysis for Scaffold Technology by End-Use - Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 68: Rest of World 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 34
Note: Product cover images may vary from those shown
  • 3D Biotek LLC
  • Avacta Life Sciences Limited
  • Becton
  • Corning Inc.
  • Dickinson and Company
  • Marticel GmbH
  • Merck and Company
  • Molecular Matrix Inc.
  • Nanofiber Solutions
  • NuVasive, Inc.
  • Pelo Biotech GmbH
  • ReproCELL Europe Ltd.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
Adroll
adroll